Saquinavir Unmasked: An Adrenoceptor Agonist In Disguise

Authored by

Tahoe Team

Released on

April 30, 2025

Authored by

Tahoe Team

Released on

April 30, 2025

Summary

Tahoe-100M revealed that Saquinavir unexpectedly mimics mechanisms such as adrenoceptor agonism, explaining clinical off-target effects discovered after decades of clinical usage.

Read on the Tahoe Blog

Our Work

Latest from our team

We’ve raised $30M to build the foundational dataset for Virtual Cell Models

Tahoe Therapeutics Raises $30M to Build World’s Largest Dataset for Training AI Models of Human Cell

Introducing TahoeDive at Databricks AI + Agents 2025

Announcing TahoeDive

Unveiling Tahoe Deep Dive Hackathon

Stay up to date with
what we’re releasing.